ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1178

Novel Quantification of MRI Provides a More Sensitive Outcome Measure Than Ramris

Michael A. Bowes1, Gwenael Guillard1, Eleanor Gill1, Graham R. Vincent1, Elizabeth Hensor2, Jane E. Freeston3,4, Edward M. Vital4, P. Bird5, Paul Emery4 and Philip G. Conaghan6, 1Imorphics Ltd, Manchester, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 4NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., United Kingdom, Leeds, United Kingdom, 5Combined Rheumatology Practice, Sydney, Australia, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Imaging and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging (MRI)

Session Type: Abstract Submissions (ACR)

Background/Purpose

 There is increasing need for sensitive, objective outcome measures in rheumatoid arthritis (RA). MRI is more sensitive than clinical examination and X-rays, using a semi-quantitative score (OMERACT RAMRIS). The objective was to use statistical shape models (SSMs) to identify RA pathology, and compare rates of change with RAMRIS in a RA population treated with a biologic therapy.

Methods

 MR images of the hand were acquired from 45 established, active (mean (SD) DAS28 = 5.4(1.1), seropositive) RA patients who received a single cycle of rituximab at 0 months in an open label study.  DAS28 improved by mean (SD) 1.7(1.4). Subjects were imaged at 0,3,6,9 & 12 months.  Hand bones were segmented using SSMs; resulting bone surfaces were used to quantify erosion and oedema (inside bone), synovitis and 3D joint space width (3DJSW, outside bone). RAMRIS scoring was performed by a single experienced reader blinded to time point. Multilevel linear regression analysis was used to model changes over time. Quantitative values were adjusted for differences in scale using total bone area at baseline. Observations were nested within patients; random slopes for time were included. Non-linear changes were modelled with polynomial terms. Likelihood ratio (LR) tests were used to compare nested models. Accuracy of automated segmentation was examined using point-to-surface distance between automated and manually segmented bone surfaces.

Results

Quantitative synovitis decreased over time; the extent of the change varied between patients (Table 1). By contrast, there was no change over time in RAMRIS synovitis. There was no change in quantitative or RAMRIS erosion and no inter-patient variation. In some patients there was evidence of cubic change in quantitative oedema; with relatively rapid change between 0 and 3m. There was no evidence of changes in RAMRIS oedema. There was strong evidence of change over time for 3DJSW (LR test chi-square=22.0, p<0.001), though the result was complex, with the most responsive patient showing increase in joint space width, while others showed a decrease. Mean accuracy of automatically generated bone surfaces was 0.2 mm (Table 2); 90th percentile 0.44 mm

Conclusion

Fully automatic quantitative analysis of RAMRIS measures is now practical, and showed change for synovitis and oedema where RAMRIS did not.  3DJSW is a novel measure that needs careful interpretation as it includes more than one type of change. Quantitative analysis depends upon accurate and automatic identification of all hand bones; these results show excellent accuracy of around 1/3 pixel.

Table 1

Table 2

 


Disclosure:

M. A. Bowes,

Imorphics Ltd,

4,

Imorphics Ltd,

3;

G. Guillard,

Imorphics Ltd,

1,

Imorphics Ltd,

3;

E. Gill,

Imorphics Ltd,

3;

G. R. Vincent,

Imorphics Ltd,

4,

Imorphics Ltd,

3;

E. Hensor,
None;

J. E. Freeston,
None;

E. M. Vital,

Roche Pharmaceuticals,

8,

GSK,

8,

NIHR clinician scientist fellowship,

2;

P. Bird,

Abbvie,

8,

Pfizer Inc,

8,

Roche Pharmaceuticals,

8,

Celgene,

8,

Janssen Pharmaceutica Product, L.P.,

8,

UCB,

8;

P. Emery,

AbbVie, Bristol-Myers Squibb (BMS), MSD, Novartis, Pfizer Inc, Roche, and UCB Pharma,

2,

AbbVie, Bristol-Myers Squibb (BMS), MSD, Novartis, Pfizer Inc, Roche, and UCB Pharma,

5;

P. G. Conaghan,

Abbvie,

8,

Merck Human Health,

8,

Novartis Pharmaceutical Corporation,

8,

Pfizer Inc,

8,

Roche Pharmaceuticals,

8,

UCB,

8.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-quantification-of-mri-provides-a-more-sensitive-outcome-measure-than-ramris/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences